OPTIMARK (gadoversetamide) injection Label

First Page		Document Content
Date: 2014-11-25 11:08:36 Medicine Nephrogenic systemic fibrosis Organochlorides Gadolinium Magnetic resonance imaging Renal failure Lorazepam Gadoversetamide MRI contrast agent Chemistry Nephrology Matter		OPTIMARK (gadoversetamide) injection Label Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 350,73 KB Share Document on Facebook

	OPTIMARK (gadoversetamide) injection Label DocID: KSKv - View Document
	AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Page: 2 of DocID: D2qm - View Document
	Microsoft Word - GBCA Advisory Committee Meeting Briefing Document - Optimark - Errata.doc DocID: Cets - View Document
	OptiMARK™ 0.5 mmol/mL (Gadoversetamide Injection) PRESCRIBING INFORMATION Rx only Mallinckrodt Inc. May 2013 DocID: oanB - View Document
	May[removed]OptiMARK~ (gadoversetamide injection) For Intravenous Injection Only Mallinckrodt Inc. DocID: j2xA - View Document